 |
Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Issa J. Dahabreh, Helen Linardou, Fotios Siannis, George Fountzilas, Samuel Murray (p. 620) |
|
Is There an Entity of Chemically Induced BCR-ABL-Positive Chronic Myelogenous Leukemia? Marshall A. Lichtman (p. 645) |
|
Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma Franz Buchegger, Oliver W. Press, Angelika Bischof Delaloye, Nicolas Ketterer (p. 657) |
|
Characteristics and Outcome of Pediatric Patients Enrolled in Phase I Oncology Trials AeRang Kim, Elizabeth Fox, Katherine Warren, Susan M. Blaney, Stacey L. Berg, Peter C. Adamson, Madeleine Libucha, Elena Byrley, Frank M. Balis, Brigitte C. Widemann (p. 679) |
|
Modern Radiotherapy as Part of Combined Modality Treatment in Locally Advanced Non-Small Cell Lung Cancer: Present Status and Future Prospects Jan P. van Meerbeeck, Sabine Meersschout, Rebecca De Pauw, Indira Madani, Wilfried De Neve (p. 700) |
|
FDA Drug Approval Summary: Nelarabine (ArranonR) for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma Martin H. Cohen, John R. Johnson, Robert Justice, Richard Pazdur (p. 709) |
|
The Oncologist Online is grateful for the support of:
|
